Ronald H. Abrahams
Keine laufenden Positionen mehr
Karriereverlauf von Ronald H. Abrahams
Ehemalige bekannte Positionen von Ronald H. Abrahams
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Winston Laboratories, Inc.
 Winston Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Winston Laboratories, Inc. manufactures pharmaceutical products. It discovers, develops and commercializes therapeutics for pain. The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters. Winston Laboratories was founded by Joel E. Bernstein and is headquartered in Vernon Hills, IL. | Geschäftsführer | - | 16.01.2009 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.1994 | 01.01.1994 |
| ERGO SCIENCE CORPORATION | Präsident | - | - |
| REATA PHARMACEUTICALS, INC. | Geschäftsführer | - | - |
Ausbildung von Ronald H. Abrahams
| University of Illinois | Undergraduate Degree |
| Loyola University of Chicago | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Winston Laboratories, Inc.
Winston Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Winston Laboratories, Inc. manufactures pharmaceutical products. It discovers, develops and commercializes therapeutics for pain. The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters. Winston Laboratories was founded by Joel E. Bernstein and is headquartered in Vernon Hills, IL. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Ergo Science Corp.
 Ergo Science Corp. Publishing: Books/MagazinesConsumer Services Ergo Science Corp. engages in the provision of business information. It operates indirectly through its subsidiaries. The company was founded on January 23, 1990 and is headquartered in Birmingham, AL. | Consumer Services |
- Börse
- Insiders
- Ronald H. Abrahams
- Erfahrung
